89bio
ETNB
ETNB
145 hedge funds and large institutions have $1.08B invested in 89bio in 2023 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
145
Holders Change
+39
Holders Change %
+36.79%
% of All Funds
2.32%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
60
Increased
48
Reduced
29
Closed
20
Calls
$55.5M
Puts
$25M
Net Calls
+$30.5M
Net Calls Change
+$25.5M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$45.2M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$41.5M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$37.5M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$35.8M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$33.7M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$46.6M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$31.2M |
| 3 |
CC
Commodore Capital
New York
|
-$9.65M |
| 4 |
Walleye Capital
New York
|
-$6.11M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$5.78M |
